Praxis Precision Medicines I (PRAX) Technical Analysis
$52.26▲3.4%
Insights
- Praxis Precision Medicines I is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Praxis Precision Medicines I stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Praxis Precision Medicines I stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Praxis Precision Medicines I stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 72.07 | Sell |
Stochastic | 77.5, 75.95 | Neutral |
Ultimate Oscillator | 57.42 | Neutral |
Stochastic Relative Strength Index | 100.0, 94.78 | Neutral |
Moving Average Convergence Divergence | 2.23, 1.67 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 46.63 | Buy |
20 | 45.06 | Buy |
50 | 41.55 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 47.48 | Buy |
20 | 45.59 | Buy |
50 | 43.5 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 47.05 | Buy |
20 | 45.69 | Buy |
50 | 41.69 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 49.77 | Buy |
20 | 48.44 | Buy |
50 | 43.0 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 50.63 | Buy |
20 | 49.41 | Buy |
50 | 48.5 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 52.9 |
Resistance L2 | 51.81 |
Resistance L1 | 51.05 |
Pivot Point | 49.96 |
Support L1 | 49.2 |
Support L2 | 48.11 |
Support L3 | 47.35 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.